These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37803082)

  • 1. MDMA-assisted therapy for PTSD passes phase III trial.
    Mullard A
    Nat Rev Drug Discov; 2023 Nov; 22(11):863. PubMed ID: 37803082
    [No Abstract]   [Full Text] [Related]  

  • 2. Premise, promise and challenges of MDMA assisted therapy for PTSD.
    Madero S; Alvarez OD
    Eur Neuropsychopharmacol; 2023 May; 70():19-20. PubMed ID: 36806884
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic investigation with MDMA (ecstasy)].
    Bouso Saiz JC; Gómez-Jarabo G
    Med Clin (Barc); 2003 Sep; 121(8):318; author reply 318-9. PubMed ID: 14499096
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
    Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R
    J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The re-emergence of hallucinogenic research.
    Begola MJ; Dowben JS
    Perspect Psychiatr Care; 2018 Oct; 54(4):523-526. PubMed ID: 29464720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA Therapy for PTSD: Inching Closer to-or Farther From-Approval?
    Davitian L
    Sr Care Pharm; 2024 Aug; 39(8):311-314. PubMed ID: 39080866
    [No Abstract]   [Full Text] [Related]  

  • 7. MDMA to Treat PTSD in Adults.
    Latimer D; Stocker MD; Sayers K; Green J; Kaye AM; Abd-Elsayed A; Cornett EM; Kaye AD; Varrassi G; Viswanath O; Urits I
    Psychopharmacol Bull; 2021 Jun; 51(3):125-149. PubMed ID: 34421149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecstasy (MDMA) dependence.
    Jansen KL
    Drug Alcohol Depend; 1999 Jan; 53(2):121-4. PubMed ID: 10080038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Psychedelic Assisted Therapy" Must Not Be Retired.
    Deckel GM; Lepow LA; Guss J
    Am J Psychiatry; 2024 Jan; 181(1):77-78. PubMed ID: 38161309
    [No Abstract]   [Full Text] [Related]  

  • 10. MDMA assisted therapy: Three papers are retracted as FDA rejects PTSD application.
    Mahase E
    BMJ; 2024 Aug; 386():q1798. PubMed ID: 39137950
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress and promise for the MDMA drug development program.
    Feduccia AA; Holland J; Mithoefer MC
    Psychopharmacology (Berl); 2018 Feb; 235(2):561-571. PubMed ID: 29152674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of psychedelic agents.
    Pathania R
    Br J Psychiatry; 2015 May; 206(5):433. PubMed ID: 25934305
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of MDMA-assisted therapy for PTSD on self-experience.
    van der Kolk BA; Wang JB; Yehuda R; Bedrosian L; Coker AR; Harrison C; Mithoefer M; Yazar-Klosinki B; Emerson A; Doblin R
    PLoS One; 2024; 19(1):e0295926. PubMed ID: 38198456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD.
    Marseille E; Kahn JG; Yazar-Klosinski B; Doblin R
    PLoS One; 2020; 15(10):e0239997. PubMed ID: 33052965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.
    Bouso JC; Doblin R; Farré M; Alcázar MA; Gómez-Jarabo G
    J Psychoactive Drugs; 2008 Sep; 40(3):225-36. PubMed ID: 19004414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA).
    Shinozuka K; Tabaac BJ; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS
    Am J Ther; 2024 Mar-Apr 01; 31(2):e141-e154. PubMed ID: 38518271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MDMA-assisted therapy for PTSD].
    Thorarinsdottir H; Gudmundsdottir B; Sigurdsson E
    Laeknabladid; 2024 May; 110(5):254-261. PubMed ID: 38713560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of potential psychedelic treatments for PTSD.
    Henner RL; Keshavan MS; Hill KP
    J Neurol Sci; 2022 Aug; 439():120302. PubMed ID: 35700643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert opinions on implementation of MDMA-assisted therapy in Europe: critical appraisal towards training, clinical practice, and regulation.
    Herpers J; Maximets N; van Dongen NNN; Zijlmans J; Vermetten E
    Eur J Psychotraumatol; 2024; 15(1):2378651. PubMed ID: 39113624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial.
    Marseille E; Mitchell JM; Kahn JG
    PLoS One; 2022; 17(2):e0263252. PubMed ID: 35213554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.